Cargando…

A pan-cancer analysis reveals role of clusterin (CLU) in carcinogenesis and prognosis of human tumors

Clusterin (CLU) is a chaperone-like protein that has been demonstrated to have a direct relationship with cancer occurrence, progression, or metastasis. Clusterin was downregulated in tumor tissues using three datasets of tongue squamous carcinoma from the Gene Expression Omnibus. We further retriev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Yizhe, Du, Qiao, Cui, Tiehan, Lu, Yuying, Niu, Guangliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846084/ https://www.ncbi.nlm.nih.gov/pubmed/36685863 http://dx.doi.org/10.3389/fgene.2022.1056184

Ejemplares similares

Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations
por: Bettens, Karolien, et al.
Publicado: (2015)

Isoorientin ameliorates H(2)O(2)-induced apoptosis and oxidative stress in chondrocytes by regulating MAPK and PI3K/Akt pathways
por: Cui, Tiehan, et al.
Publicado: (2023)

Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
por: Cai, Rongrong, et al.
Publicado: (2016)

CluMan
por: Lopienski, Sebastian
Publicado: (2008)

Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells
por: Huang, Hai, et al.
Publicado: (2014)

ATM Regulates Insulin-Like Growth Factor 1-Secretory Clusterin (IGF-1-sCLU) Expression that Protects Cells against Senescence
por: Luo, Xiuquan, et al.
Publicado: (2014)

Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p
por: Mu, Lihua, et al.
Publicado: (2020)

The combined risk effect among BIN1, CLU, and APOE genes in Alzheimer’s disease
por: dos Santos, Lígia Ramos, et al.
Publicado: (2020)

Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment
por: Yuan, Shangkun, et al.
Publicado: (2022)

Pan-cancer analysis reveals NAA50 as a cancer prognosis and immune infiltration-related biomarker
por: Fang, Tao, et al.
Publicado: (2022)

Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3
por: Wu, Yinteng, et al.
Publicado: (2023)

CluMan - Cluster management toolsuit
por: Siket, M, et al.
Publicado: (2010)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

Chromobox Homolog 8 (CBX8) in Human Tumor Carcinogenesis and Prognosis: A Pancancer Analysis Using Multiple Databases
por: Shi, Dongjie, et al.
Publicado: (2021)

Corrigendum: Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3
por: Wu, Yinteng, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis and the regulatory mechanism of AURKA, a gene associated with prognosis of ferroptosis of adrenal cortical carcinoma in the tumor micro-environment
por: Lu, Keqiang, et al.
Publicado: (2023)

A systematic pan-cancer analysis of the gasdermin (GSDM) family of genes and their correlation with prognosis, the tumor microenvironment, and drug sensitivity
por: Zheng, Yufu, et al.
Publicado: (2022)

Systematic pan-cancer analysis showed that RAD51AP1 was associated with immune microenvironment, tumor stemness, and prognosis
por: Liu, Renwang, et al.
Publicado: (2022)

CLU: A new algorithm for EST clustering
por: Ptitsyn, Andrey, et al.
Publicado: (2005)

CLU blocks HDACI-mediated killing of neuroblastoma
por: Subramanian, Chitra, et al.
Publicado: (2010)

WISP1 Predicts Clinical Prognosis and Is Associated With Tumor Purity, Immunocyte Infiltration, and Macrophage M2 Polarization in Pan-Cancer
por: Liao, Xia, et al.
Publicado: (2020)

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors
por: Zhao, Huihui, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of ALKBH7
por: Chen, Kaijie, et al.
Publicado: (2022)

An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer
por: Cong, Fengyun, et al.
Publicado: (2022)

Pan-glioma analyses reveal species- and tumor-specific regulation of neuron-glioma synapse genes by lncRNAs
por: Xiong, Wei, et al.
Publicado: (2023)

A pan-cancer analysis reveals the genetic alterations and immunotherapy of Piezo2 in human cancer
por: Liu, Xin, et al.
Publicado: (2022)

A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts Infiltration
por: Du, Kunpeng, et al.
Publicado: (2022)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers
por: Wang, Yiyang, et al.
Publicado: (2023)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Intra-Tumoral Expression of SLC7A11 Is Associated with Immune Microenvironment, Drug Resistance, and Prognosis in Cancers: A Pan-Cancer Analysis
por: He, Jiajun, et al.
Publicado: (2021)

Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors
por: Liang, Qiuju, et al.
Publicado: (2022)

Genetic Variability in CLU and Its Association with Alzheimer's Disease
por: Guerreiro, Rita J., et al.
Publicado: (2010)

CLU Polymorphisms in Patients with Pseudoexfoliation Syndrome in Polish Population
por: Lesiewska, Hanna, et al.
Publicado: (2019)

Alternative Splicing Regulation of an Alzheimer’s Risk Variant in CLU
por: Han, Seonggyun, et al.
Publicado: (2020)

sCLU as prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Jinfeng, et al.
Publicado: (2019)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2
por: Xu, Qiqi, et al.
Publicado: (2022)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy
por: Deng, Jiehua, et al.
Publicado: (2022)

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy
por: Lin, Zhengjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_glkeh3jjo7dj38oo289tcrb6bn